Center for Biologics Evaluation and Research

Results: 1843



#Item
51Research / Medicine / Clinical research / Pharmacology / Drug safety / Validation / Center for Biologics Evaluation and Research / Drug Master File / Biologic / Food and Drug Administration / Pharmaceutical industry / Pharmaceutical sciences

Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Add to Reading List

Source URL: www.fda.gov

Language: English
52Pharmaceutical industry / Microbiology / Validity / Clinical research / Validation / Recombinant DNA / Meningococcal disease / Cleaning validation / Novartis / Biology / Quality / Biotechnology

DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Center for Biologics Evaluation and Research[removed]New Hampshire Ave

Add to Reading List

Source URL: www.fda.gov

Language: English
53AstraZeneca / Vaccines / Epidemiology / Influenza / FluMist / Center for Biologics Evaluation and Research / MedImmune / Food and Drug Administration / Medicine / Health / Vaccination

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike

Add to Reading List

Source URL: www.fda.gov

Language: English
54Pharmaceutical industry / Validity / Pharmacology / Clinical research / Food and Drug Administration / Center for Biologics Evaluation and Research / Endotoxin / Novartis / Validation / Medicine / Pharmaceutical sciences / Science

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]CBER REGULATORY REVIEW MEMORANDUM Date

Add to Reading List

Source URL: www.fda.gov

Language: English
55Medicine / Clinical research / Investigational New Drug / Expanded access / Drug development / Center for Drug Evaluation and Research / Food and Drug Administration / Pharmacology / Pharmaceutical sciences

[removed]Federal Register / Vol. 80, No[removed]Tuesday, March 3, [removed]Notices TABLE 3—ESTIMATED ANNUAL REPORTING BURDEN FOR BIOLOGICS 1—Continued[removed]b), Number of submissions to FDA of ‘‘supporting informati

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2015-03-03 11:27:09
56Pharmaceutical sciences / Pharmaceuticals policy / Clinical research / Pharmaceutical industry / Drug safety / New Drug Application / Federal Food /  Drug /  and Cosmetic Act / Rad / Center for Biologics Evaluation and Research / Food and Drug Administration / Medicine / Health

Microsoft Word - 10970dft.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
57Pharmaceutical sciences / Federal Food /  Drug /  and Cosmetic Act / Center for Biologics Evaluation and Research / Office of Criminal Investigations / Center for Devices and Radiological Health / Criticism of the Food and Drug Administration / Class I recall / Food and Drug Administration / Medicine / Health

6728 ACTION: Federal Register / Vol. 80, No[removed]Friday, February 6, [removed]Notices Notice of meeting.

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2015-02-06 13:06:20
58Piperazines / Clinical research / Pharmacology / Therapeutics / United States Public Health Service / Center for Biologics Evaluation and Research / Norfloxacin / Center for Drug Evaluation and Research / Food and Drug Administration / Medicine / Pharmaceutical sciences

Federal Register / Vol. 80, No[removed]Thursday, February 26, [removed]Notices title04/0403.htm. Karl Koerper, Reports Clearance Officer. [FR Doc. 2015–03924 Filed 2–25–15; 8:45 am] BILLING CODE 4184–73–P

Add to Reading List

Source URL: www.fda.gov

Language: English
59Health / Prescription Drug User Fee Act / Center for Biologics Evaluation and Research / Biosimilar / FDA Special Protocol Assessment / New Drug Application / Generic drug / Center for Drug Evaluation and Research / Biologic / Food and Drug Administration / Pharmaceutical sciences / Medicine

Microsoft Word - 16618dft.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
60Clinical research / Center for Devices and Radiological Health / Center for Food Safety and Applied Nutrition / Regulatory science / Center for Biologics Evaluation and Research / Food and Drug Administration / Medicine / Health

FDA’s Initiatives to Closing the Regulatory Science Knowledge Gap Leslie D. Wheelock, RN, MS Director, Office of Scientific Professional Development Office of the Chief Scientist

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE